查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609588

临床试验影像市场规模、份额、趋势分析报告：按模式、按治疗领域、按服务、按最终用途、按地区、按细分市场、预测，2025-2030 年

Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Modality (Computed Tomography Scan, Magnetic Resonance Imaging), By Therapeutic Area, By Services, By End Use, Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10个工作天内

价格

临床试验影像市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球临床试验影像市场规模将达到19.1亿美元，2025年至2030年复合年增长率为7.8%。

用于发现治疗慢性病的新药和治疗方法的研发支出不断增加正在推动产业成长。从体内测试获得的图像用于确定药物活性。临床试验影像可提供快速、详细且准确的筛检。在临床试验的各个阶段，对临床试验影像诊断的需求正在迅速增加。医疗图像在临床试验中用作主要、定量和替代生物标记。

临床试验设计包括患者群体选择、基于生物标记的分层、各种治疗分配方法、高效可靠的终点选择和替代终点检验以及样本大小计算、试验模拟、适应性试验设置、统计分析、中期分析和分析。

市场上的公司提供分析测试服务、药物动力学、解释和动态服务，以加强临床开发。 IXICO 提供加速神经科学临床试验的先进技术。该公司的成像生物标记有助于衡量神经成像治疗方法的安全性和有效性。成像生物标记对于放射学解释很有用。这使得能够解释中枢神经系统 MRI 扫描，并增强对药物安全性和受试者合格持续监测的评估。

临床试验成像市场报告亮点

  • 解读与分析服务业在2024年占据最大市场占有率，为30.95%，预计2025年至2030年复合年增长率为8.4%，对于确保临床研究中影像资料的准确性和可靠性具有重要意义。的角色
  • 2024年，生技和製药公司板块占最大份额，达28.7%。导致这一领域占据主导地位的一个因素是需要开发新的药物和治疗方法来治疗慢性疾病。
  • 2024年，肿瘤领域占比最大，为23.63%。癌症患者的高盛行率以及对治疗各种类型癌症的创新治疗方法的持续需求预计将推动市场成长。
  • 委外研发机构(CRO) 产业预计在预测期内将以 8.5% 的复合年增长率大幅增长，因为它在新药和慢性病治疗方法的开发中发挥着至关重要的作用。
  • 由于老年人口不断增长、慢性病以及对治疗方案的需求不断增加，北美在 2024 年占据市场主导地位，销售额份额为 47.93%。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章临床试验影像市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床试验影像市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章 临床试验影像市场：按模式估计与趋势分析

  • 细分仪表板
  • 临床试验影像市场：模态变异分析
  • 按模式分類的临床试验影像市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 电脑断层扫描
  • 磁振造影
  • X射线
  • 超音波
  • 光学同调断层扫描(OCT)
  • 其他方式

第五章临床试验影像市场：按治疗领域估计和趋势分析

  • 细分仪表板
  • 临床试验影像市场：治疗区域变异分析
  • 临床试验影像市场治疗领域展望
  • 2018-2030年市场规模、预测及趋势分析
  • 神经血管疾病
  • 心血管疾病
  • 整形外科和 MSK 疾病
  • 肿瘤学
  • 眼科
  • 肾臟病学
  • 其他治疗领域

第六章 临床试验影像市场：按服务分类的估计和趋势分析

  • 细分仪表板
  • 临床试验影像市场：服务变化分析
  • 临床试验影像市场服务展望
  • 2018-2030年市场规模、预测及趋势分析
  • 临床试验设计与咨询服务
  • 阅读与分析服务
  • 营运影像服务
  • 系统和技术支援服务
  • 计划和资料管理

第七章 临床试验影像市场：最终用途的估计与趋势分析

  • 细分仪表板
  • 临床试验影像市场：最终用途变异分析
  • 按最终用途分類的临床试验成像市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 生物技术和製药公司
  • 医疗设备製造商
  • 学术和政府研究机构
  • 受託研究机构（CRO）
  • 其他最终用户

第八章 临床试验影像市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场简介
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2024年主要企业市场占有率分析
    • IXICO plc
    • Navitas Life Sciences
    • Resonance Health
    • ProScan Imaging
    • Radiant Sage LLC
    • Medpace
    • Biomedical Systems Corp.
    • Cardiovascular Imaging Technologies
    • Intrinsic Imaging
    • BioTelemetry
Product Code: GVR-2-68038-628-8

Clinical Trial Imaging Market Growth & Trends:

The global clinical trial imaging market size is expected to reach USD 1.91 billion by 2030, registering a CAGR of 7.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing research and development spending to discover new drugs and therapies to treat chronic diseases is propelling the industry growth. Images obtained from the internal examination of the body are used to determine drug activity. Clinical trial imaging provides rapid, detailed, and accurate screening. The need for clinical trial imaging is rapidly increasing in all phases of trials. Medical imaging in clinical trials is used as a primary, quantitative, and surrogate biomarker.

The clinical trial design includes selecting patient population, stratification based on biomarkers, different methods for allocation treatments, choosing efficient and reliable endpoints and validation of surrogate endpoints, calculating sample size, trial simulations, adaptive trial set-up, statistical and interim analysis, and assisting clients to deal with regulatory authorities such as EMA and FDA to discuss study design or defend study results.

Market players provide analytical testing services, pharmacokinetic, reading, and pharmacodynamics services for enhanced clinical development. IXICO offers advanced technologies for catalyzing clinical trials in neuroscience. Imaging biomarkers by the company help in measuring the safety and effectiveness of therapies used for neuro-imaging. Imaging biomarkers are effective in radiological reads. This provides the reading of MRI scans for central neuro to enhance the assessment of ongoing monitoring of drug safety and subject eligibility

Clinical Trial Imaging Market Report Highlights:

  • The reading and analytical services segment held the largest market share at 30.95% in 2024 and is expected to grow at a CAGR of 8.4% from 2025 to 2030, highlighting its critical role in ensuring the accuracy and reliability of imaging data in clinical research.
  • The biotechnology and pharmaceutical companies segment accounted for the largest share of 28.7% in 2024. The factor attributing to the dominance of this segment is the need to develop new drugs and therapies to cure chronic diseases.
  • Oncology segment held the largest market share of 23.63% in 2024. High prevalence of cancer cases and the constant need for new and innovative therapies to treat various types of cancer are expected to fuel the market growth.
  • The contract research organizations (CROs) segment is expected to grow significantly with a CAGR of 8.5% over the forecast period, owing to its essential role in developing new drugs and therapies for chronic diseases.
  • North America dominated the market with a revenue share of 47.93% in 2024 due to the increasing geriatric population, along with chronic diseases and growing demand for treatment options.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Therapeutic Area
    • 1.2.3. Services
    • 1.2.4. End Use
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Therapeutic area outlook
    • 2.2.3. Services outlook
    • 2.2.4. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Clinical Trial Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing number of pharmaceutical and biotechnological companies
      • 3.2.1.2. Growing number of contract research organization (CRO)
      • 3.2.1.3. Increasing research and development investments
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of machineries and installations
  • 3.3. Clinical Trial Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Clinical Trial Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Clinical Trial Imaging Market: Modality Movement Analysis
  • 4.3. Clinical Trial Imaging Market by Modality Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Computed Tomography Scan
    • 4.5.1. Computed Tomography Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Magnetic Resonance Imaging
    • 4.6.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. X-Ray
    • 4.7.1. X-Ray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Ultrasound
    • 4.8.1. Ultrasound Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Optical Coherence Tomography (OCT)
    • 4.9.1. Optical Coherence Tomography (OCT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Other Modalities
    • 4.10.1. Other Modalities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Imaging Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Clinical Trial Imaging Market: Therapeutic Area Movement Analysis
  • 5.3. Clinical Trial Imaging Market by Therapeutic Area Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Neurovascular Diseases
    • 5.5.1. Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Cardiovascular Diseases
    • 5.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Orthopedics & MSK Disorders
    • 5.7.1. Orthopedics & MSK Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Oncology
    • 5.8.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Ophthalmology
    • 5.9.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Nephrology
    • 5.10.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Other Therapeutic Areas
    • 5.11.1. Other Therapeutic Areas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Imaging Market: Services Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Clinical Trial Imaging Market: Services Movement Analysis
  • 6.3. Clinical Trial Imaging Market by Services Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Clinical Trial Design and Consultation Services
    • 6.5.1. Clinical Trial Design and Consultation Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Reading and Analytical Services
    • 6.6.1. Reading and Analytical Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Operational Imaging Services
    • 6.7.1. Operational Imaging Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. System and Technology Support Services
    • 6.8.1. System and Technology Support Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Project and Data Management
    • 6.9.1. Project and Data Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Imaging Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Clinical Trial Imaging Market: End Use Movement Analysis
  • 7.3. Clinical Trial Imaging Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Biotechnology and Pharmaceutical Companies
    • 7.5.1. Biotechnology and Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Medical Devices Manufacturers
    • 7.6.1. Medical Devices Manufacturers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Academic and Government Research Institutes
    • 7.7.1. Academic and Government Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Contract Research Organizations (CROs)
    • 7.8.1. Contract Research Organizations (CROs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Other End Users
    • 7.9.1. Other End Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Clinical Trial Imaging Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.8.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.8. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. Middle East & Africa
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
    • 9.1.1 Company/Competition Categorization
    • 9.1.2. Innovators
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
    • 9.2.2. Key customers
    • 9.2.3. Key company market share analysis, 2024
    • 9.2.4. IXICO plc
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Navitas Life Sciences
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Resonance Health
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. ProScan Imaging
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Radiant Sage LLC
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Medpace
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Biomedical Systems Corp.
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Cardiovascular Imaging Technologies
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Intrinsic Imaging
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. BioTelemetry
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 5 North America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 6 North America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 9 U.S. clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 10 U.S. clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 12 Canada clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 13 Canada clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 14 Canada clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mexico clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 16 Mexico clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 17 Mexico clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 18 Mexico clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 21 Europe clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 22 Europe clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 23 Europe clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 25 Germany clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 26 Germany clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 27 Germany clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 28 UK clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 29 UK clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 30 UK clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 31 UK clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 32 France clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 33 France clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 34 France clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 35 France clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Italy clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 37 Italy clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 38 Italy clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 39 Italy clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Spain clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 41 Spain clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 42 Spain clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 43 Spain clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Sweden clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 45 Sweden clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 46 Sweden clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 47 Sweden clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Denmark clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 49 Denmark clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 50 Denmark clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 51 Denmark clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Norway clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 53 Norway clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 54 Norway clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 55 Norway clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 61 China clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 62 China clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 63 China clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 64 China clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Japan clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 66 Japan clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 67 Japan clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 68 Japan clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 69 India clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 70 India clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 71 India clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 72 India clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Australia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 74 Australia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 75 Australia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 76 Australia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 77 South Korea clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 78 South Korea clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 79 South Korea clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 80 South Korea clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Thailand clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 82 Thailand clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 83 Thailand clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 84 Thailand clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 86 Latin America clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 87 Latin America clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 88 Latin America clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 89 Latin America clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Brazil clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 91 Brazil clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 92 Brazil clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 93 Brazil clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 95 Argentina clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 96 Argentina clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 97 Argentina clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa clinical trial imaging market, by region, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 103 South Africa clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 104 South Africa clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 105 South Africa clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 106 South Africa clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 112 UAE clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 113 UAE clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 114 UAE clinical trial imaging market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
  • Table 116 Kuwait clinical trial imaging market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 117 Kuwait clinical trial imaging market, by services, 2018 - 2030 (USD Million)
  • Table 118 Kuwait clinical trial imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 clinical trial imaging market: market outlook
  • Fig. 14 clinical trial imaging market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Clinical trial imaging market driver impact
  • Fig. 20 Clinical trial imaging market restraint impact
  • Fig. 21 Clinical trial imaging market strategic initiatives analysis
  • Fig. 22 Clinical trial imaging market: Modality movement analysis
  • Fig. 23 Clinical trial imaging market: Modality outlook and key takeaways
  • Fig. 24 Computed tomography scan market estimates and forecast, 2018 - 2030
  • Fig. 25 Magnetic resonance imaging market estimates and forecast, 2018 - 2030
  • Fig. 26 X-Ray market estimates and forecast, 2018 - 2030
  • Fig. 27 Ultrasound market estimates and forecast, 2018 - 2030
  • Fig. 28 Optical coherence tomography (OCT) market estimates and forecast, 2018 - 2030
  • Fig. 29 Other modalities market estimates and forecast, 2018 - 2030
  • Fig. 30 Clinical trial imaging market: Therapeutic area movement analysis
  • Fig. 31 Clinical trial imaging market: Therapeutic area outlook and key takeaways
  • Fig. 32 Neurovascular diseases market estimates and forecast, 2018 - 2030
  • Fig. 33 Cardiovascular diseases market estimates and forecast, 2018 - 2030
  • Fig. 34 Oncology market estimates and forecast, 2018 - 2030
  • Fig. 35 Ophthalmology market estimates and forecast, 2018 - 2030
  • Fig. 36 Nephrology market estimates and forecast, 2018 - 2030
  • Fig. 37 Other therapeutic areas market estimates and forecast, 2018 - 2030
  • Fig. 38 Clinical trial imaging market: Services movement analysis
  • Fig. 39 Clinical trial imaging market: Services outlook and key takeaways
  • Fig. 40 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
  • Fig. 41 Reading and analytical services market estimates and forecast, 2018 - 2030
  • Fig. 42 Operational imaging services market estimates and forecast, 2018 - 2030
  • Fig. 43 System and technology support services market estimates and forecast, 2018 - 2030
  • Fig. 44 Project and data management market estimates and forecast, 2018 - 2030
  • Fig. 45 Clinical trial imaging market: End use movement analysis
  • Fig. 46 Clinical trial imaging market: End use outlook and key takeaways
  • Fig. 47 Biotechnology companies market estimates and forecast, 2018 - 2030
  • Fig. 48 Medical devices manufacturers market estimates and forecast, 2018 - 2030
  • Fig. 49 Academic and government research institutes market estimates and forecast, 2018 - 2030
  • Fig. 50 Contract research organizations (CROs) market estimates and forecast, 2018 - 2030
  • Fig. 51 Other end users market estimates and forecast, 2018 - 2030
  • Fig. 52 Global clinical trial imaging market: Regional movement analysis
  • Fig. 53 Global clinical trial imaging market: Regional outlook and key takeaways
  • Fig. 54 Global market shares and leading players
  • Fig. 55 North America market share and leading players
  • Fig. 56 Europe market share and leading players
  • Fig. 57 Asia Pacific market share and leading players
  • Fig. 58 Latin America market share and leading players
  • Fig. 59 Middle East & Africa market share and leading players
  • Fig. 60 North America
  • Fig. 61 North America market estimates and forecast, 2018 - 2030
  • Fig. 62 U.S.
  • Fig. 63 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 64 Canada
  • Fig. 65 Canada market estimates and forecast, 2018 - 2030
  • Fig. 66 Mexico
  • Fig. 67 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 68 Europe
  • Fig. 69 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 70 UK
  • Fig. 71 UK market estimates and forecast, 2018 - 2030
  • Fig. 72 Germany
  • Fig. 73 Germany market estimates and forecast, 2018 - 2030
  • Fig. 74 France
  • Fig. 75 France market estimates and forecast, 2018 - 2030
  • Fig. 76 Italy
  • Fig. 77 Italy market estimates and forecast, 2018 - 2030
  • Fig. 78 Spain
  • Fig. 79 Spain market estimates and forecast, 2018 - 2030
  • Fig. 80 Sweden
  • Fig. 81 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 82 Denmark
  • Fig. 83 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 84 Norway
  • Fig. 85 Norway market estimates and forecast, 2018 - 2030
  • Fig. 86 Asia Pacific
  • Fig. 87 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 88 China
  • Fig. 89 China market estimates and forecast, 2018 - 2030
  • Fig. 90 Japan
  • Fig. 91 Japan market estimates and forecast, 2018 - 2030
  • Fig. 92 India
  • Fig. 93 India market estimates and forecast, 2018 - 2030
  • Fig. 94 Australia
  • Fig. 95 Australia market estimates and forecast, 2018 - 2030
  • Fig. 96 South Korea
  • Fig. 97 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 98 Thailand
  • Fig. 99 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 100 Latin America
  • Fig. 101 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 102 Brazil
  • Fig. 103 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 104 Argentina
  • Fig. 105 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 106 Middle East and Africa
  • Fig. 107 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 108 Saudi Arabia
  • Fig. 109 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 110 South Africa
  • Fig. 111 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 112 UAE
  • Fig. 113 UAE market estimates and forecast, 2018 - 2030
  • Fig. 114 Kuwait
  • Fig. 115 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 116 Participant categorization- Clinical trial imaging market
  • Fig. 117 Market share of key market players- Clinical trial imaging market